Oxford begins first human trial of Bundibugyo Ebola vaccine
The University of Oxford has launched the first human trials for a Bundibugyo ebolavirus vaccine in the UK.
🌍 Cross-language spread
This story first appeared in 🇧🇷 Portuguese coverage — 10.5 hours before Newsylist detected it in English news.
Detected by matching proper nouns and figures that survive translation. Times reflect when each edition's coverage was first indexed.
Velocity timeline
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
The University of Oxford and the Oxford Vaccine Group have commenced the first human trials of a vaccine targeting the Bundibugyo ebolavirus. These trials are taking place in the UK.
Coverage from Reuters, BBC, and Sky News emphasizes that the trial launch occurs eight weeks into an Ebola emergency. The effort is backed by CEPI, as noted in reports from the organization and Oxford.
Further developments will depend on the progression of these initial human trials conducted by the Oxford Vaccine Group.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated just now.
Quick answers
Where are the vaccine trials taking place?
The human trials are being conducted in the UK.
Who is backing the Bundibugyo ebolavirus vaccine trial?
The trial is backed by CEPI.
When did the trials begin relative to the Ebola emergency?
According to the BBC, the trials started eight weeks into the Ebola emergency.
Coverage (6)
- The Ugandan city where the race for a new Ebola vaccine will be won or lost The Telegraph · 14h ago
- Oxford's Bundibugyo ebolavirus response University of Oxford · 14h ago
- Human trials of new Ebola vaccine set to begin in UK Sky News · 14h ago
- CEPI-backed Bundibugyo ebolavirus vaccine trial launched by Oxford Vaccine Group CEPI · 14h ago
- UK starts first vaccine trial, eight weeks into Ebola emergency BBC · 14h ago
- Oxford begins first human trial of Bundibugyo Ebola vaccine Reuters · 14h ago broke it first
People, places & organizations
Topics
Related trends
Genomic epidemiology of the ongoing 2026 Bundibugyo Virus Disease outbreak in the Democratic Republic of the Congo
Genomic surveillance and logistical challenges define the current response to the 2026 Bundibugyo Virus Disease outbreak in the Democratic Republic of the Congo.